Waheed Sadia, Bayas Angel, Hindi Fawzi, Rizvi Zufe, Espinosa Patricio S
Neurology, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, USA.
Cureus. 2021 Feb 18;13(2):e13426. doi: 10.7759/cureus.13426.
Since the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, in December 2019, Coronavirus - 19 (COVID-19) has become a global pandemic with multiple neurological complications. In December 2020, two vaccines have been approved in the United States for the prevention of COVID-19. We report a case of Guillain-Barre Syndrome (GBS) after receiving the first dose of Pfizer - COVID-19 vaccine.
自2019年12月中国武汉报告首例严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病例以来，新型冠状病毒肺炎（COVID-19）已成为一种伴有多种神经并发症的全球大流行病。2020年12月，两种疫苗在美国被批准用于预防COVID-19。我们报告了1例在接种第一剂辉瑞COVID-19疫苗后发生吉兰-巴雷综合征（GBS）的病例。
Zotero 插件
